Wangzhi Li
Stock Analyst at Ladenburg Thalmann
(2.77)
# 1,654
Out of 4,829 analysts
3
Total ratings
66.67%
Success rate
27.26%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Wangzhi Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRYS Krystal Biotech | Initiates: Buy | $23 | $139.43 | -83.50% | 1 | Oct 18, 2017 | |
| LPTX Leap Therapeutics | Initiates: Buy | $180 | $0.38 | +47,887.20% | 1 | Mar 7, 2017 | |
| CLRB Cellectar Biosciences | Initiates: Buy | $270 | $0.26 | +102,134.00% | 1 | Dec 21, 2016 |
Krystal Biotech
Oct 18, 2017
Initiates: Buy
Price Target: $23
Current: $139.43
Upside: -83.50%
Leap Therapeutics
Mar 7, 2017
Initiates: Buy
Price Target: $180
Current: $0.38
Upside: +47,887.20%
Cellectar Biosciences
Dec 21, 2016
Initiates: Buy
Price Target: $270
Current: $0.26
Upside: +102,134.00%